Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

USA - NYSE:MPW - US58463J3041 - REIT

5.25 USD
-0.14 (-2.6%)
Last: 10/9/2025, 5:05:00 PM
5.29 USD
+0.04 (+0.76%)
After Hours: 10/9/2025, 5:05:00 PM
Fundamental Rating

4

Taking everything into account, MPW scores 4 out of 10 in our fundamental rating. MPW was compared to 130 industry peers in the Diversified REITs industry. MPW scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MPW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
MPW had a positive operating cash flow in the past year.
In multiple years MPW reported negative net income over the last 5 years.
Each year in the past 5 years MPW had a positive operating cash flow.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

With a Return On Assets value of -9.45%, MPW is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
MPW has a Return On Equity of -29.62%. This is amonst the worse of the industry: MPW underperforms 89.23% of its industry peers.
With a Return On Invested Capital value of 1.93%, MPW is not doing good in the industry: 66.15% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for MPW is in line with the industry average of 3.02%.
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROIC 1.93%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

MPW has a Operating Margin of 38.49%. This is amongst the best in the industry. MPW outperforms 83.08% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 96.46%, MPW belongs to the best of the industry, outperforming 97.69% of the companies in the same industry.
MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.49%
PM (TTM) N/A
GM 96.46%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MPW has been increased compared to 1 year ago.
MPW has more shares outstanding than it did 5 years ago.
MPW has a worse debt/assets ratio than last year.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

MPW has an Altman-Z score of 0.01. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
MPW has a worse Altman-Z score (0.01) than 73.08% of its industry peers.
MPW has a debt to FCF ratio of 931.91. This is a negative value and a sign of low solvency as MPW would need 931.91 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 931.91, MPW is in line with its industry, outperforming 53.08% of the companies in the same industry.
A Debt/Equity ratio of 2.00 is on the high side and indicates that MPW has dependencies on debt financing.
MPW has a worse Debt to Equity ratio (2.00) than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Altman-Z 0.01
ROIC/WACC0.32
WACC6.13%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 2.07 indicates that MPW has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.07, MPW belongs to the top of the industry, outperforming 82.31% of the companies in the same industry.
MPW has a Quick Ratio of 2.07. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.07, MPW belongs to the best of the industry, outperforming 82.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for MPW have decreased strongly by -820.83% in the last year.
Looking at the last year, MPW shows a very strong growth in Revenue. The Revenue has grown by 27.66%.
MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)-820.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.7%
Revenue 1Y (TTM)27.66%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-9.83%

3.2 Future

MPW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.79% yearly.
Based on estimates for the next years, MPW will show a small growth in Revenue. The Revenue will grow by 2.71% on average per year.
EPS Next Y93.69%
EPS Next 2Y43.44%
EPS Next 3Y27.79%
EPS Next 5YN/A
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 34.65, which means the current valuation is very expensive for MPW.
MPW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MPW is cheaper than 69.23% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MPW to the average of the S&P500 Index (23.30), we can say MPW is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 34.65
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

MPW's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MPW is more expensive than 65.38% of the companies in the same industry.
MPW's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 304.79
EV/EBITDA 16.26
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

MPW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MPW's earnings are expected to grow with 27.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.44%
EPS Next 3Y27.79%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.81%, MPW is a good candidate for dividend investing.
MPW's Dividend Yield is comparable with the industry average which is at 6.68.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 5.81%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
DP-16.42%
EPS Next 2Y43.44%
EPS Next 3Y27.79%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (10/9/2025, 5:05:00 PM)

After market: 5.29 +0.04 (+0.76%)

5.25

-0.14 (-2.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners59.4%
Inst Owner Change0%
Ins Owners17.29%
Ins Owner Change12.97%
Market Cap3.16B
Analysts51.76
Price Target4.95 (-5.71%)
Short Float %33.19%
Short Ratio17.53
Dividend
Industry RankSector Rank
Dividend Yield 5.81%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-11 2025-09-11 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5843.9%
Min EPS beat(2)-11757.5%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3817.81%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-1947.02%
EPS beat(12)3
Avg EPS beat(12)-1329.14%
EPS beat(16)7
Avg EPS beat(16)-980.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.51%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-1.65%
Revenue beat(16)6
Avg Revenue beat(16)-1.31%
PT rev (1m)-1.45%
PT rev (3m)-6.85%
EPS NQ rev (1m)-65.39%
EPS NQ rev (3m)-59.08%
EPS NY rev (1m)-111.54%
EPS NY rev (3m)-4225%
Revenue NQ rev (1m)-2.15%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-2.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.65
P/S 3.42
P/FCF 304.79
P/OCF 16.78
P/B 0.65
P/tB 0.65
EV/EBITDA 16.26
EPS(TTM)-2.21
EYN/A
EPS(NY)0.15
Fwd EY2.89%
FCF(TTM)0.02
FCFY0.33%
OCF(TTM)0.31
OCFY5.96%
SpS1.53
BVpS8.04
TBVpS8.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROCE 2.45%
ROIC 1.93%
ROICexc 2%
ROICexgc 2.08%
OM 38.49%
PM (TTM) N/A
GM 96.46%
FCFM 1.12%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.25%
ROICexcg growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Debt/EBITDA 12.68
Cap/Depr 43.72%
Cap/Sales 19.27%
Interest Coverage 0.92
Cash Conversion 24.7%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 0.01
F-Score4
WACC6.13%
ROIC/WACC0.32
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-820.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.7%
EPS Next Y93.69%
EPS Next 2Y43.44%
EPS Next 3Y27.79%
EPS Next 5YN/A
Revenue 1Y (TTM)27.66%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-9.83%
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%
EBIT growth 1Y54.29%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.92%
EBIT Next 3Y37.51%
EBIT Next 5Y20.65%
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.04%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%